{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:52:31Z","timestamp":1783608751808,"version":"3.55.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T00:00:00Z","timestamp":1573430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T00:00:00Z","timestamp":1573430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1038\/s41375-019-0634-2","type":"journal-article","created":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T15:03:29Z","timestamp":1573484609000},"page":"1192-1196","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Cytogenetic subclone formation and evolution in progressive smoldering multiple myeloma"],"prefix":"10.1038","volume":"34","author":[{"given":"Maximilian","family":"Merz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1277-310X","authenticated-orcid":false,"given":"Thomas","family":"Hielscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Schult","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6226-1252","authenticated-orcid":false,"given":"Elias K.","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc S.","family":"Raab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Hillengass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Seckinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Hose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Granzow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Jauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Goldschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,11]]},"reference":[{"key":"634_CR1","doi-asserted-by":"publisher","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","volume":"113","author":"O Landgren","year":"2009","unstructured":"Landgren O, Kyle RA, Pfeiffer RM, Katzmann JA, Caporaso NE, Hayes RB, et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood. 2009;113:5412\u20137.","journal-title":"Blood"},{"key":"634_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-018-0077-4","volume":"8","author":"A Lakshman","year":"2018","unstructured":"Lakshman A, Rajkumar SV, Buadi FK, Binder M, Gertz MA, Lacy MQ, et al. Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria. Blood Cancer J. 2018;8:59.","journal-title":"Blood Cancer J"},{"key":"634_CR3","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1200\/JCO.2012.48.4923","volume":"31","author":"K Neben","year":"2013","unstructured":"Neben K, Jauch A, Hielscher T, Hillengass J, Lehners N, Seckinger A, et al. Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load. J Clin Oncol J Am Soc Clin Oncol. 2013;31:4325\u201332.","journal-title":"J Clin Oncol J Am Soc Clin Oncol"},{"key":"634_CR4","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1038\/leu.2013.86","volume":"27","author":"S Rajkumar","year":"2013","unstructured":"Rajkumar S, Gupta V, Fonseca R, Dispenzieri A, Gonsalves W, Larson D, et al. Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myeloma. Leukemia. 2013;27:1738\u201344.","journal-title":"Leukemia"},{"key":"634_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05058-y","volume":"9","author":"N Bolli","year":"2018","unstructured":"Bolli N, Maura F, Minvielle S, Gloznik D, Szalat R, Fullam A, et al. Genomic patterns of progression in smoldering multiple myeloma. Nat Commun. 2018;9:3363.","journal-title":"Nat Commun"},{"key":"634_CR6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41375-018-0206-x","volume":"33","author":"AK Dutta","year":"2019","unstructured":"Dutta AK, Fink JL, Grady JP, Morgan GJ, Mullighan CG, To LB, et al. Subclonal evolution in disease progression from MGUS\/SMM to multiple myeloma is characterised by clonal stability. Leukemia. 2019;33:457\u201368.","journal-title":"Leukemia"},{"key":"634_CR7","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1182\/blood.V128.22.4415.4415","volume":"128","author":"M Merz","year":"2016","unstructured":"Merz M, Hielscher T, Seckinger A, Hose D, Bertsch U, Neben K, et al. Longitudinal fluorescence in situ hybridization at primary diagnosis and relapse reveals clonal evolution after autologous stem cell transplantation in multiple myeloma. Blood. 2016;128:4415\u20134415.","journal-title":"Blood"},{"key":"634_CR8","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1182\/bloodadvances.2018023200","volume":"2","author":"T Bochtler","year":"2018","unstructured":"Bochtler T, Merz M, Hielscher T, Granzow M, Hoffmann K, Kr\u00e4mer A, et al. Cytogenetic intraclonal heterogeneity of plasma cell dyscrasia in AL amyloidosis as compared with multiple myeloma. Blood Adv. 2018;2:2607\u201318.","journal-title":"Blood Adv"},{"key":"634_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1182\/bloodadvances.2017013334","volume":"2","author":"M Merz","year":"2018","unstructured":"Merz M, Jauch A, Hielscher T, Bochtler T, Sch\u00f6nland SO, Seckinger A, et al. Prognostic significance of cytogenetic heterogeneity in patients with newly diagnosed multiple myeloma. Blood Adv. 2018;2:1\u20139.","journal-title":"Blood Adv"},{"key":"634_CR10","first-page":"202200","volume":"2018","author":"JR Jones","year":"2019","unstructured":"Jones JR, Weinhold N, Ashby C, Walker BA, Wardell C, Pawlyn C, et al. Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly diagnosed patients. Haematologica. 2019;2018:202200.","journal-title":"Haematologica"},{"key":"634_CR11","doi-asserted-by":"publisher","unstructured":"Manier S, Salem KZ, Park J, Landau DA, Getz G, Ghobrial IM Genomic complexity of multiple myeloma and its clinical implications. Nat Rev Clin Oncol. 2016. https:\/\/doi.org\/10.1038\/nrclinonc.2016.122.","DOI":"10.1038\/nrclinonc.2016.122"},{"key":"634_CR12","doi-asserted-by":"publisher","first-page":"e116","DOI":"10.3324\/haematol.2015.136929","volume":"101","author":"N Weinhold","year":"2016","unstructured":"Weinhold N, Kirn D, Seckinger A, Hielscher T, Granzow M, Bertsch U, et al. Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma. Haematologica. 2016;101:e116\u2013119.","journal-title":"Haematologica"},{"key":"634_CR13","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1182\/blood-2007-02-069625","volume":"110","author":"D Gonz\u00e1lez","year":"2007","unstructured":"Gonz\u00e1lez D, Burg M, van der, Garc\u00eda-Sanz R, Fenton JA, Langerak AW, Gonz\u00e1lez M, et al. Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma. Blood. 2007;110:3112\u201321.","journal-title":"Blood"},{"key":"634_CR14","doi-asserted-by":"publisher","unstructured":"Landgren O, Hofmann JN, McShane CM, Santo L, Hultcrantz M, Korde N et al. Association of immune marker changes with progression of monoclonal gammopathy of undetermined significance to multiple myeloma. JAMA Oncol. 2019. https:\/\/doi.org\/10.1001\/jamaoncol.2019.1568.","DOI":"10.1001\/jamaoncol.2019.1568"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-019-0634-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-019-0634-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-019-0634-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T21:26:17Z","timestamp":1630704377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-019-0634-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,11]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["634"],"URL":"https:\/\/doi.org\/10.1038\/s41375-019-0634-2","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,11]]},"assertion":[{"value":"14 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}